Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD

INTRODUCTION: The effects of long-term and uninterrupted tolvaptan treatment on autosomal dominant polycystic kidney disease (ADPKD) are unclear. Therefore, a more than 3-year continuous treatment study was performed. METHODS: From the Kyorin University cohort, 299 patients were surveyed and 179 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Higashihara, Eiji, Nutahara, Kikuo, Itoh, Masayuki, Okegawa, Takatsugu, Tambo, Mistuhiro, Yamaguchi, Tsuyoshi, Nakamura, Yu, Taguchi, Satoru, Kaname, Shinya, Yokoyama, Kenichi, Yoshioka, Tatsuya, Fukuhara, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820994/
https://www.ncbi.nlm.nih.gov/pubmed/35155866
http://dx.doi.org/10.1016/j.ekir.2021.11.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820994/
https://www.ncbi.nlm.nih.gov/pubmed/35155866
http://dx.doi.org/10.1016/j.ekir.2021.11.034

Ejemplares similares